Genetic variation in the upstream region of ERG and prostate cancer

Cancer Causes and Control

Volumn 20, Issue 7, 2009, Pages 1173-1180

  Lindström, Sara ^a,b   Adami, Hans Olov ^b,c   Bälter, Katarina ^b   Xu, Jianfeng ^d   Zheng, S Lilly ^d   Sun, Jielin ^d   Stattin, Pär ^a   Grönberg, Henrik ^b   Wiklund, Fredrik ^b  

^a UMEÅ UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

ERG; Haplotype; Polymorphism; Prostate cancer; Survival

Indexed keywords

TRANSCRIPTION FACTOR ERG;

5' UNTRANSLATED REGION; ADULT; AGED; ARTICLE; CANCER RISK; CANCER SURVIVAL; CASE CONTROL STUDY; CONTROLLED STUDY; GENE FUSION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTO ONCOGENE; SINGLE NUCLEOTIDE POLYMORPHISM; SWEDEN;

AGED; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; PROTO-ONCOGENES; RISK FACTORS; SERINE ENDOPEPTIDASES; SURVIVAL ANALYSIS; TRANS-ACTIVATORS;

EID: 68449096264     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9305-3     Document Type: Article

References (27)

1. SA Tomlins DR Rhodes S Perner 2205 Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 310 5748 644 648 10.1126/science.1117679
2. S Perner F Demichelis R Beroukhim 2006 TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer Cancer Res 66 17 8337 8341 10.1158/0008-5472.CAN-06-1482 (Pubitemid 44449140)
3. N Cerveira FR Ribeiro A Peixoto 2006 TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions Neoplasia 8 10 826 832 10.1593/neo.06427 (Pubitemid 44564838)
4. K Iljin M Wolf H Edgren 2006 TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming Cancer Res 66 21 10242 10246 10.1158/0008-5472.CAN-06-1986 (Pubitemid 44799738)
5. J Wang Y Cai C Ren M Ittmann 2006 Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer Cancer Res 66 17 8347 8351 10.1158/0008-5472.CAN-06-1966 (Pubitemid 44449142)
6. G Petrovics A Liu S Shaheduzzaman 2005 Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome Oncogene 24 23 3847 3852 10.1038/sj.onc.1208518 (Pubitemid 40826884)
7. AB Rajput MA Miller A De Luca 2007 Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers J Clin Pathol 60 11 1238 1243 10.1136/jcp.2006.043810 (Pubitemid 350084545)
8. AD Darnel CJ Lafargue RT Vollmer J Corcos TA Bismar 2009 TMPRSS2-ERG fusion is frequently observed in gleason pattern 3 prostate cancer in a canadian cohort Cancer Biol Ther 8 2 125 130
9. R Mehra SA Tomlins R Shen 2007 Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer Mod Pathol 20 5 538 544 10.1038/modpathol.3800769 (Pubitemid 46631996)
10. F Demichelis K Fall S Perner 2007 TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort Oncogene 26 31 4596 4599 10.1038/sj.onc.1210237 (Pubitemid 47037039)
11. Jhavar S, Brewer D, Edwards S et al (2008) Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer. BJU Int (28 Nov, in press)
12. LM FitzGerald I Agalliu K Johnson 2008 Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer BMC Cancer 8 230 10.1186/1471-2407-8- 230
13. OR Saramäki AE Harjula PM Martikainen RL Vessella TL Tammela T Visakorpi 2008 TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis Clin Cancer Res 14 11 3395 3400 10.1158/1078-0432.CCR-07- 2051
14. R Mehra SA Tomlins J Yu 2008 Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer Cancer Res 68 10 3584 3590 10.1158/0008-5472.CAN-07-6154
15. RK Nam L Sugar W Yang 2007 Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer Br J Cancer 97 12 1690 1695 10.1038/sj.bjc.6604054 (Pubitemid 350249347)
16. G Attard J Clark L Ambroisine 2008 Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer Oncogene 27 3 253 263 10.1038/sj.onc.1210640
17. KG Hermans R van Marion H van Dekken G Jenster WM van Weerden J Trapman 2006 TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer Cancer Res 66 22 10658 10663 10.1158/0008-5472.CAN-06-1871 (Pubitemid 44876959)
18. S Lindstrom F Wiklund HO Adami KA Balter J Adolfsson H Gronberg 2006 Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development Cancer Res 66 22 11077 11083 10.1158/0008-5472.CAN- 06-3024 (Pubitemid 44877009)
19. SB Gabriel SF Schaffner H Nguyen 2002 The structure of haplotype blocks in the human genome Science 296 5576 2225 2229 10.1126/science.1069424 (Pubitemid 34680308)
20. DO Stram CA Haiman JN Hirschhorn 2003 Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study Hum Hered 55 1 27 36 10.1159/000071807 (Pubitemid 36928743)
21. C Jurinke D van den Boom CR Cantor H Koster 2002 Automated genotyping using the DNA MassArray technology Methods Mol Biol 187 179 192
22. R Development Core Team (2006) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria
23. DJ Schaid CM Rowland DE Tines RM Jacobson GA Poland 2002 Score tests for association between traits and haplotypes when linkage phase is ambiguous Am J Hum Genet 70 2 425 434 10.1086/338688 (Pubitemid 34112296)
24. StataCorp (2005) Stata Statistical Software: release 8. StataCorp LP, College Station, TX
25. DA Tregouet L Tiret 2004 Cox proportional hazards survival regression in haplotype-based association analysis using the Stochastic-EM algorithm Eur J Hum Genet 12 11 971 974 10.1038/sj.ejhg.5201238 (Pubitemid 39462132)
26. DJ Schaid SK McDonnell KE Zarfas 2006 Pooled genome linkage scan of aggressive prostate cancer: results from the international consortium for prostate cancer genetics Hum Genet 120 4 471 485 10.1007/s00439-006-0219-9 (Pubitemid 44669782)
27. P Stattin R Johansson JE Damber 2003 Non-systematic screening for prostate cancer in Sweden-survey from the National Prostate Cancer Registry Scand J Urol Nephrol 37 6 461 465 10.1080/00365590310015778 (Pubitemid 38091158)